Business Context and Reporting Period
This Form 8-K is filed by GHL Acquisition Corp. (GHQ) on July 29, 2009. The filing relates to the proposed acquisition of Iridium Holdings LLC (Iridium). GHQ is a special purpose acquisition company (SPAC) formed to effect a merger with Iridium. The filing details material definitive agreements entered into to restructure and repurchase warrants issued in GHQ's initial public offering (IPO) contingent upon the closing of the Iridium acquisition.
Key Financial Metrics and Transaction Details
The filing does not provide standard operating financial metrics (revenue, profit, cash flow) for GHQ or Iridium. Instead, it outlines specific financial terms of the warrant restructuring:
- Warrant Repurchase: GHQ agreed to purchase approximately 12.4 million existing warrants for a total consideration of approximately $3.1 million in cash and $12.4 million in GHQ common stock.
- Stock Valuation Cap: The number of shares issued for the repurchase is based on the price of a future equity offering, capped at $10.00 per share.
- Warrant Restructuring: Approximately 14.4 million existing warrants will be restructured with the following terms:
- Exercise price increased to 115% of the future offering price (capped at $10.00).
- Exercise period extended by two years to February 2015.
- Redemption price increased to $18.00 per share.
- Post-Closing Warrant Count: Upon closing, approximately 13.7 million warrants will remain at the original $7.00 exercise price, and 14.4 million will be restructured warrants.
Material Changes Versus Prior Period
The filing represents a material change in GHQ's capital structure and obligations. Prior to this agreement, GHQ held outstanding warrants from its IPO with an exercise price of $7.00. The new agreements modify the terms of approximately 26.8 million warrants (roughly 50% of the total outstanding at the time) to reduce dilution and align warrant economics with the proposed acquisition. This is a one-time transactional event rather than a period-over-period operational change.
Guidance, Outlook, and Risks
- Contingency: All warrant purchase and restructuring agreements are subject to the closing of the Iridium acquisition. If the acquisition does not close, these agreements will not be executed.
- Regulatory Risk: GHQ must file a resale registration statement for the restructured warrants within 15 business days of issuance. If the SEC does not declare it effective within 30 business days, warrant holders have the right to sell the warrants back to GHQ for cash based on a specific formula.
- Management Commentary: GHQ is soliciting proxies from stockholders to approve the acquisition. The filing explicitly states that the information is not complete and may be changed, urging investors to read the definitive proxy statement before voting.
- Participants: Greenhill & Co., Inc. (4.0 million warrants) and GHQ executives Scott L. Bok and Robert H. Niehaus (0.4 million warrants) agreed to exchange their warrants into the restructured terms.
Important Facts for Investor Verification
- Verify the status of the definitive proxy statement and the scheduled special meeting to approve the Iridium acquisition.
- Confirm the terms of the future equity offering which will determine the exact number of shares issued for the warrant repurchase and the final exercise price of restructured warrants.
- Monitor the SEC effectiveness of the resale registration statement for restructured warrants to assess the risk of cash redemption obligations.
- Review the preliminary proxy statement for detailed financial information regarding Iridium Holdings LLC, which is not contained in this 8-K.